SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-21-014900
Filing Date
2021-07-29
Accepted
2021-07-29 16:31:11
Documents
49
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q cort-20210630.htm   iXBRL 10-Q 1017927
2 EX-31.1 cort63021ex311.htm EX-31.1 9529
3 EX-31.2 cort63021ex312.htm EX-31.2 9615
4 EX-32.1 cort63021ex321.htm EX-32.1 5190
5 EX-32.2 cort63021ex322.htm EX-32.2 5116
  Complete submission text file 0001628280-21-014900.txt   4005207

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cort-20210630.xsd EX-101.SCH 25661
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT cort-20210630_cal.xml EX-101.CAL 58959
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT cort-20210630_def.xml EX-101.DEF 71088
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cort-20210630_lab.xml EX-101.LAB 327133
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cort-20210630_pre.xml EX-101.PRE 192205
11 EXTRACTED XBRL INSTANCE DOCUMENT cort-20210630_htm.xml XML 618023
Mailing Address 149 COMMONWEALTH DRIVE MENLO PARK CA 94025
Business Address 149 COMMONWEALTH DRIVE MENLO PARK CA 94025 650.688.8803
CORCEPT THERAPEUTICS INC (Filer) CIK: 0001088856 (see all company filings)

IRS No.: 770487658 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-50679 | Film No.: 211127882
SIC: 2834 Pharmaceutical Preparations